Over DKK 3 billion (USD 413 million) raised by BioInnovation Institute portfolio companies to date
- Portfolio company Adcendo Aps, today announces extension of Series A financing to 82M EUR.
- BII publishes its 2022 Impact Report outlining the success of its portfolio companies in the past year.
- BII’s ambition is to support early-stage life science projects and start-ups for the benefit of people and society.
- Sourcing science globally and translating it to commercially viable companies in the innovative Nordic ecosystem.
